Improve Investigator Payment and Budget Management While Addressing Sunshine & FMV Compliance
Source: DrugDev
Like its peers of all sizes operating in the United States, this Top 20 Pharma has faced the challenge of anticipating and addressing the Physician Payment Sunshine Provision (PPSP) within the Patient Protection and Affordable Care Act (PPACA) of 2009. Signed into law on March 23, 2010 with final guidance issued February 1, 2013, the “Sunshine Act” within PPACA requires drug and medical device manufacturers to publicly report gifts and payments made to “covered recipients.” Such recipients include physicians and teaching hospitals.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more